Transradial approach in patients with ST-elevation myocardial infarction treated with abciximab results in fewer bleeding complications: Data from EUROTRANSFER registry

Coronary Artery Disease

Volumn 21, Issue 5, 2010, Pages 292-297

  Siudak, Zbigniew ^a   Zawislak, Barbara ^a   Dziewierz, Artur ^a   Rakowski, Tomasz ^a   Jakala, Jacek ^a   Bartus, Stanislaw ^a   Noworolnik, Beata ^a   Zasada, Wojciech ^a   Dubiel, Jacek S ^a   Dudek, Dariusz ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

acute coronary syndrome; femoral; percutaneous coronary intervention; radial

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; CLOPIDOGREL; HEPARIN; HIRULOG; LOW MOLECULAR WEIGHT HEPARIN; ANTITHROMBOCYTIC AGENT; IMMUNOGLOBULIN F(AB) FRAGMENT; MONOCLONAL ANTIBODY;

ARTICLE; BLEEDING; BLOOD TRANSFUSION; BODY WEIGHT; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; CONTROLLED STUDY; DISEASE REGISTRY; DRUG EFFICACY; DRUG SAFETY; EUROPE; FEMALE; HEMATOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STROKE; AGED; CHI SQUARE DISTRIBUTION; COMPARATIVE STUDY; FEMORAL ARTERY; HEMORRHAGE; MIDDLE AGED; MULTICENTER STUDY; MYOCARDIAL INFARCTION; PUNCTURE; RADIAL ARTERY; REGISTER; RISK; RISK ASSESSMENT; RISK FACTOR; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTIBODIES, MONOCLONAL; BLOOD TRANSFUSION; CHI-SQUARE DISTRIBUTION; EUROPE; FEMALE; FEMORAL ARTERY; HEMATOMA; HEMORRHAGE; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; ODDS RATIO; PLATELET AGGREGATION INHIBITORS; PUNCTURES; RADIAL ARTERY; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME; ANGIOPLASTY, BALLOON, CORONARY;

EID: 77954657940     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCA.0b013e32833aa6d1     Document Type: Article

References (23)

1. Van de Werf F, Bax J, Betriu A, Blomstrom-Lundqvist C, Crea F, Falk V, et al. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the task force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology. Eur Heart J 2008; 29:2909-2945.
2. Yusuf S, Mehta SR, Chrolavicius S, Afzal R, Pogue J, Granger CB, et al. Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction. The OASIS-6 randomized trial. JAMA 2006; 295:1519-1530.
3. Gibson CM, Murphy SA, Montalescot G, Morrow DA, Ardissino D, Cohen M, et al.; ExTRACT-TIMI 25 Investigators. Percutaneous coronary intervention in patients receiving enoxaparin or unfractionated heparin after fibrinolytic therapy for ST-segment elevation myocardial infarction in the ExTRACT-TIMI 25 trial. J Am Coll Cardiol 2007; 49:2238-2246.
4. Lincoff AM, Kleiman NS, Kereiakes DJ, Feit F, Bittl JA, Jackman JD, et al.; REPLACE-2 Investigators. Long-term efficacy of bivalirudin and provisional glycoprotein IIb/IIIa blockade versus heparin and planned glycoprotein IIb/ IIIa blockade during percutaneous coronary revascularization: REPLACE-2 randomized trial. JAMA 2004; 292:696-703.
5. Stone GW,Witzenbichler B, Guagliumi G, Peruga JZ, Brodie BR, Dudek D, et al.; HORIZONS-AMI Trial Investigators. Bivalirudin during primary PCI in acute myocardial infarction. N Engl J Med 2008; 358:2218-2230.
6. Lewis BS, Mehta SR, Fox KA, Halon DA, Zhao F, Peters RJ, et al.; CURE Trial Investigators. Benefit of clopidogrel according to timing of percutaneous coronary intervention in patients with acute coronary syndromes: further results from the clopidogrel in unstable angina to prevent recurrent events (CURE) study. Am Heart J 2005; 150:1177-1184.
7. McKay RG, Dada MR, Mather JF, Mennet RR, Murphy DJ, Maloney KW, et al. Comparison of outcomes and safety of ''facilitated'' versus primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction. Am J Cardiol 2009; 103:316-321.
8. Fuchs S, Kornowski R, Teplitsky I, Brosh D, Lev E, Vaknin-Assa H, et al. Major bleeding complicating contemporary primary percutaneous coronary interventions-incidence, predictors, and prognostic implications. Cardiovasc Revasc Med 2009; 10:88-93.
9. Campeau L. Percutaneous radial artery approach for coronary angiography. Cathet Cardiovasc Diagn 1989; 16:3-7.
10. Kiemeneij F, Laarman GJ. Percutaneous transradial artery approach for coronary stent implantation. Cathet Cardiovasc Diagn 1993; 30:173-178.
11. Chodó r P, Krupa H, Kurek T, Sokal A, Swierad M,Was T, et al. RADIal versus femoral approach for percutaneous coronary interventions in patients with acute myocardial infarction (RADIAMI): a prospective, randomized, single-center clinical trial. Cardiol J 2009; 16:332-340.
12. Ruzsa Z, Ungi I, Horvá th T, Sepp R, Zimmermann Z, Thury A, et al. Five-year experience with transradial coronary angioplasty in ST-segment-elevation myocardial infarction. Cardiovasc Revasc Med 2009; 10:73-79.
13. Galli M, Di Tano G, Mameli S, Butti E, Politi A, Zerboni S, Ferrari G. Ad hoc transradial coronary angioplasty strategy: experience and results in a single centre. Int J Cardiol 2003; 92:275-280.
14. Kiemeneij F, Laarman GJ, Odekerken D, Slagboom T, Van der Wieken R. A randomized comparison of percutaneous transluminal coronary angioplasty by the radial, brachial and femoral approaches: the access study. J Am Coll Cardiol 1997; 29:1269-1275.
15. Mann T, Cubeddu G, Bowen J, Schneider JE, Arrowood M, Newman WN, et al. Stenting in acute coronary syndromes: a comparison of radial versus femoral access sites. J Am Coll Cardiol 1998; 32:572-576.
16. Vorobcsuk A, Kó nyi A, Aradi D, Horvá th IG, Ungi I, Louvard Y, Komó csi A. Transradial versus transfemoral percutaneous coronary intervention in acute myocardial infarction systematic overview and meta-analysis. Am Heart J 2009; 158:814-821.
17. Hetherington SL, Adam Z, Morley R, de Belder MA, Hall JA, Muir DF, et al. Primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction: changing patterns of vascular access, radial versus femoral artery. Heart 2009; 95:1612-1618.
18. De Carlo M, Borelli G, Gistri R, Ciabatti N, Mazzoni A, Arena M, Petronio AS. Effectiveness of the transradial approach to reduce bleedings in patients undergoing urgent coronary angioplasty with GPIIb/IIIa inhibitors for acute coronary syndromes. Catheter Cardiovasc Interv 2009; 74:408-415.
19. Dudek D, Siudak Z, Janzon M, Birkemeyer R, Aldama-Lopez G, Lettieri C, et al.; EUROTRANSFER Registry Investigators. European registry on patients with ST-elevation myocardial infarction transferred for mechanical reperfusion with a special focus on early administration of abciximab - EUROTRANSFER registry. Am Heart J 2008; 156:1147-1154.
20. Rakowski T, Siudak Z, Dziewierz A, Birkemeyer R, Legutko J, Mielecki W, et al. Early abciximab administration before transfer for primary percutaneous coronary interventions for ST-elevation myocardial infarction reduces 1-year mortality in patients with high-risk profile. Results from EUROTRANSFER registry. Am Heart J 2009; 158:569-575.
21. Kiemeneij F. Cost-effectiveness of transradial coronary access. J Invasive Cardiol 2007; 19:354.
22. Mehran R, Pocock SJ, Stone GW, Clayton TC, Dangas GD, Feit F, et al. Associations of major bleeding and myocardial infarction with the incidence and timing of mortality in patients presenting with non-ST-elevation acute coronary syndromes: a risk model from the ACUITY trial. Eur Heart J 2009; 30:1457-1466.
23. Mehilli J, Kastrati A, Schulz S, Früngel S, Nekolla SG, Moshage W, et al.; Bavarian Reperfusion Alternatives Evaluation-3 (BRAVE-3) Study Investigators. Abciximab in patients with acute ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention after clopidogrel loading: a randomized double-blind trial. Circulation 2009; 119:1933-1940.